Filing Details
- Accession Number:
- 0001209191-12-034803
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-06-20 20:38:08
- Reporting Period:
- 2012-06-19
- Filing Date:
- 2012-06-20
- Accepted Time:
- 2012-06-20 20:38:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1103390 | Ardea Biosciences Inc. | RDEA | Pharmaceutical Preparations (2834) | 943200380 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1202094 | Kimberly Manhard | 4939 Directors Place San Diego CA 92121 | Svp, Regulatory & Dev Ops | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2012-06-19 | 4,375 | $5.95 | 14,575 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-06-19 | 2,906 | $14.95 | 17,481 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2012-06-19 | 5,548 | $15.69 | 23,029 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-06-19 | 12,829 | $31.96 | 10,200 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2012-06-19 | 4,375 | $0.00 | 4,375 | $5.95 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2012-06-19 | 2,906 | $0.00 | 2,906 | $14.95 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2012-06-19 | 5,548 | $0.00 | 5,548 | $15.69 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-07-25 | No | 4 | M | Direct | |
| 9,595 | 2019-12-15 | No | 4 | M | Direct | |
| 0 | 2018-01-01 | No | 4 | M | Direct |
Footnotes
- Includes 230 shares acquired under the Ardea Biosciences, Inc. 2000 Employee Stock Purchase Plan on June 12, 2012.
- 25% of the shares subject to the stock option vest and become exercisable on July 26, 2008. The remaining shares vest in equal monthly installments over the following 3 years.
- The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the Date of Grant (12/16/09).
- 25% of the shares subject to the stock option vest and become exercisable on January 1, 2009. The remaining shares vest in equal monthly installments over the following 3 years.
Billionaire Hedge Funds
